Intelligent Bio Solutions

Historical price data

Intelligent Bio Solutions is on a mission to redefine diagnostic testing by delivering intelligent, rapid, and non-invasive solutions that improve quality of life. The company has successfully transitioned from development to commercialization, with its core fingerprint-based drug screening system deployed in international markets like the UK and Europe. Its strategic focus is on securing regulatory clearance and commercial entry into the large U.S. drug testing market, while leveraging its proprietary sweat analysis platform for future diagnostic applications. Key achievements include CE marking, UKCA certification, and initial commercial sales.

Proprietary diagnostic platform using fingerprint sweat analysis, employing fluorescent immunoassays on a disposable cartridge read by a portable spectrometer to detect drug metabolites and other biomarkers non-invasively.

INBS competes primarily against entrenched lab-based urine testing (Quest, LabCorp) and point-of-care oral fluid tests (Abbott, OraSure). Its key differentiator is the non-invasive, dignified, and tamper-resistant fingerprint collection method, though it must overcome market familiarity with cheaper, established alternatives.